Cedrus LLC Sells 217 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Cedrus LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 16.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,103 shares of the company’s stock after selling 217 shares during the quarter. Cedrus LLC’s holdings in HCA Healthcare were worth $448,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Resonant Capital Advisors LLC bought a new stake in HCA Healthcare during the third quarter valued at $200,000. Raymond James & Associates grew its holdings in shares of HCA Healthcare by 5.2% during the third quarter. Raymond James & Associates now owns 120,759 shares of the company’s stock worth $49,080,000 after purchasing an additional 5,981 shares in the last quarter. Friedenthal Financial purchased a new stake in HCA Healthcare in the third quarter valued at approximately $50,000. Dixon Mitchell Investment Counsel Inc. increased its holdings in shares of HCA Healthcare by 6.1% in the 3rd quarter. Dixon Mitchell Investment Counsel Inc. now owns 51,411 shares of the company’s stock worth $20,899,000 after buying an additional 2,978 shares during the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of HCA Healthcare by 1.1% during the 3rd quarter. Blue Trust Inc. now owns 40,700 shares of the company’s stock worth $16,542,000 after acquiring an additional 448 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 17,202 shares of company stock valued at $6,407,273. Insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $415.54 on Friday. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $417.14. The company has a market cap of $108.84 billion, a price-to-earnings ratio of 20.71, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a fifty day simple moving average of $392.18 and a two-hundred day simple moving average of $350.34.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter last year, the firm earned $4.29 earnings per share. Research analysts predict that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.64%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. KeyCorp started coverage on HCA Healthcare in a research note on Friday, October 11th. They set an “overweight” rating and a $475.00 price objective on the stock. Finally, Barclays increased their target price on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have given a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $365.65.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.